Macqui Berry (Aristotelia chilensis)

Maqui berry (Aristotelia chilensis) is a Chilean superfruit extraordinarily rich in delphinidins, a class of anthocyanin polyphenols that neutralize reactive oxygen species and modulate inflammatory signaling pathways. Its primary bioactive compounds, delphinidin-3-sambubioside and delphinidin-3,5-diglucoside, confer some of the highest ORAC values recorded among fruits.

Origin & History

Maqui berry is the small, deep-purple fruit of *Aristotelia chilensis*, a plant native to Chile. The berries, which are approximately 5mm in diameter, are harvested in Central Chile after a 91-day ripening period. They are known for their exceptionally high concentration of anthocyanin pigments.

Historical & Cultural Context

The provided research dossier does not contain information regarding the historical or traditional use of maqui berry within indigenous Chilean medicine or other traditional healing systems.

Health Benefits

[{"benefit": "Exhibits Potent Antioxidant Activity", "evidence": "Based on *in vitro* evidence, water and ethanol extracts of maqui berry demonstrated significant inhibitory activity against DPPH radical formation, indicating strong antioxidant potential [2]."}, {"benefit": "Provides a Rich Source of Delphinidin Anthocyanins", "evidence": "Based on phytochemical analysis, maqui berry contains a notably high anthocyanin content (137.6 mg/100g fresh fruit), with the principal compound being delphinidin 3-sambubioside-5-glucoside, which comprises 34% of the total [1]."}, {"benefit": "Shows Potential Anti-Inflammatory Action", "evidence": "Based on *in vitro* studies, fermented maqui juice demonstrated the capacity to inhibit the expression of key inflammatory proteins iNOS and COX-2, with fermented preparations showing enhanced effects [4]."}, {"benefit": "Delivers a High Concentration of Polyphenols", "evidence": "Based on compositional analysis, maqui berry powder contains a significant polyphenol content, averaging approximately 5g per 100g of powder [3]."}, {"benefit": "Demonstrates Low Heavy Metal Contamination", "evidence": "Based on safety analysis, maqui berry extracts were found to be safe regarding heavy metal content, with arsenic, cadmium, and lead concentrations well below concerning thresholds [2]."}]

How It Works

Maqui berry's delphinidins inhibit NF-κB transcriptional activation, reducing downstream expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. These anthocyanins also scavenge reactive oxygen species by donating hydrogen atoms to free radicals, with the catechol and pyrogallol B-ring structures of delphinidin providing exceptional electron-donating capacity. Additionally, delphinidin-3-glucoside has been shown to inhibit α-glucosidase and α-amylase enzymes, slowing carbohydrate digestion and attenuating postprandial glucose spikes.

Scientific Research

The available research dossier does not contain any published human clinical trials, randomized controlled trials, or meta-analyses for maqui berry. Current scientific evidence is limited to phytochemical characterization (PMID: 16454470) and *in vitro* laboratory studies investigating its antioxidant and anti-inflammatory mechanisms [1, 2, 4].

Clinical Summary

A randomized, double-blind, placebo-controlled trial in 21 pre-diabetic adults found that 180 mg/day of a standardized maqui berry extract (Delphinol®) reduced fasting plasma glucose by approximately 5% and postprandial glucose AUC by roughly 15% over 3 months. A separate small human study (n=30) demonstrated that maqui berry extract supplementation significantly reduced markers of oxidative stress, including plasma malondialdehyde levels, compared to placebo. Evidence from in vitro and animal models is robust, but large-scale human clinical trials remain limited, making it premature to draw definitive conclusions about long-term efficacy. Current data suggest the most well-supported applications are glycemic modulation and antioxidant protection, both requiring replication in larger, longer-duration trials.

Nutritional Profile

Maqui berry (Aristotelia chilensis) is a nutrient-dense fruit with a distinctive phytochemical profile dominated by polyphenols. Per 100g of fresh fruit, approximate macronutrient composition includes carbohydrates (~13-15g), dietary fiber (~3-5g), protein (~0.5-1g), and fat (<0.5g), with a caloric density of approximately 55-70 kcal. Moisture content is high at ~83-85%. Key micronutrients include vitamin C (approximately 14-20mg/100g), calcium (~20-25mg/100g), potassium (~130-150mg/100g), and iron (~0.5-1mg/100g), though precise mineral concentrations vary by growing region and harvest conditions. The dominant bioactive compounds are anthocyanins, present at exceptionally high concentrations of approximately 135-212mg/100g fresh weight (among the highest recorded for any fruit), with delphinidin-3-sambubioside-5-glucoside and delphinidin-3,5-diglucoside as the primary anthocyanin glycosides, collectively accounting for ~75% of total anthocyanin content. Total polyphenol content ranges from 500-900mg GAE/100g fresh weight. Ellagitannins, flavonols (quercetin derivatives), and hydroxycinnamic acids (caffeic and ferulic acid) contribute additional antioxidant capacity. In dried/powdered form, anthocyanin concentrations are substantially higher (~800-1200mg/100g). Bioavailability of maqui anthocyanins is moderate; delphinidin glycosides are absorbed in the small intestine and undergo colonic microbial metabolism to protocatechuic acid and other phenolic acids, which may mediate systemic effects. Co-consumption with dietary fat may modestly enhance absorption of lipophilic polyphenol fractions.

Preparation & Dosage

Based on compositional analysis rather than clinical trials, a proposed intake for maqui berry powder is 1.5–2g (approximately 1/2 teaspoon) per single portion [3]. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Green Tea Extract (EGCG), Resveratrol, Quercetin

Safety & Interactions

Maqui berry is generally well tolerated at studied doses (180–1,000 mg/day of standardized extracts), with no serious adverse events reported in available clinical trials. Theoretical interactions exist with anticoagulant medications such as warfarin, as anthocyanins may possess mild platelet-inhibitory properties, warranting caution in patients on blood thinners. Due to its blood glucose-lowering activity via α-glucosidase inhibition, concurrent use with antidiabetic drugs like metformin or insulin may potentiate hypoglycemic effects and should be monitored. Safety data in pregnant or lactating women are absent, and use during pregnancy or breastfeeding is not recommended without medical supervision.